Honored to present our work on AI and Hypertension Guidelines at American Heart Association Hypertension 2023 to an amazing audience and co-presenters. Serge C. Harb Samir Kapadia Cleveland Clinic Heart, Vascular & Thoracic Luke J. Laffin Hypertension Press release below 👇🏻 professional.heart.org/en/meetings/hy…

Telehealth-based delivery of cardiac rehabilitation is not yet a pragmatic option for many Medicare beneficiaries, a Cleveland Clinic study finds. The results raise questions about progress toward national cardiac rehab participation goals. Luke J. Laffin consultqd.clevelandclinic.org/lack-of-broadb…

#BreakingNews: We’ve received FDA approval for the Paradise™ Ultrasound Renal Denervation (#RDN) system – making it the FIRST US-approved RDN system to treat hypertension. 🙌 bit.ly/3sxNMpw Important Safety Information: bit.ly/473Nhm7

🚨Attention all CardioNerds !! Join #HouseTaussig 🫀and a panel of phenomenal experts tomorrow at 8:00 PM EST to discuss the revolutionary results of #SELECT 🔥 An absolute gamechanger!🤩 Can't wait to see you then! 🕗

Congratulations to Dr. George Bakris UChicago Medicine Dr Luke J. Laffin Cleveland Clinic MD and Dr. Matthew Sorrentino UChicago Medicine on the publication of #Hypertension 4e: A Companion to Braunwald's Heart Disease bit.ly/3Sx2jMp Elsevier for Medical Professionals

Glad to be coauthor with Luke J. Laffin and James deLemos in a research highlighting the role of GLP1RA on 24 hABP in SURMOUNT-1 UTSW Heart Hypertension ahajournals.org/doi/10.1161/HY…

Engaging Cleveland Clinic satellite symposium MDVIP’s National Meeting this weekend, on current state-of-the-art practices & emerging therapies in CVD risk reduction🫀 Thanks to all who joined us! Luke J. Laffin Ashish Sarraju CCF Cardiology Fellows

Great to have you work with Cleveland Clinic Heart, Vascular & Thoracic . Best of luck!

We have an opportunity for a staff position in the Clinical Section at the Cleveland Clinic. This section houses experts in ACHD, cardio oncology, sports cardiology, critical care, and general cardiology who are outstanding clinicians with a passion for edu/research Samir Kapadia

🗣️ In our 3-part #HealioExclusive, we discuss: 🔑The cardiometabolic consequences of obesity 🔑Emerging data on BP after weight loss 🔑Benefits of an obesity-first treatment strategy 📰Read part 1 here! healio.com/news/cardiolog… MS Center for Clinical and Translational Research Cleveland Clinic MD Luke J. Laffin Endocrine Today

George L Bakris Memorial Symposium on hypertension is around the corner ! It's a great opportunity to connect with the experts in the field. Please join us on Sep 12th Both in person and virtual options available: 6thannualrenalresearchret.rsvpify.com

The Future of Antihypertensive Therapies: Emerging therapies like aldosterone synthase inhibitors, GLP-1 agonists, and zilebesiran offer hope for better BP control @laffinlj ahajournals.org/doi/full/10.11…

Excellent Article on Key Concepts in Machine Learning and Clinical Applications in the Cardiac Intensive Care Unit #CICU #CritCareCards by Mayo Clinic CV’s #JacobJentzer, and Aniket Rali, MD, FACC, FCCP #DhruvSarma link.springer.com/article/10.100…

#ACC25 - Cleveland Clinic is looking forward to seeing you @ booth #10055! 🫀Stop by to engage with our staff, research team & caregivers. 🫀Several CCF Cardiology Fellows superstars will be presenting their posters. 🫀Learn about opportunities to join our CVM team Sat & Sun, 9:30-11:30am.

In the Advance-HTN phase 2b trial of the aldosterone synthase inhibitor lorundrostat in participants with uncontrolled hypertension, lorundrostat was associated with greater reductions in blood pressure than placebo. Full trial results: nej.md/4ipbCIf

Thanks Rohan Kalathiya, MD and Jonathan Paul

Congratulations to my friend and colleague, Ashish Sarraju , and the team at C5Research (Cleveland Clinic Heart, Vascular & Thoracic ) on completing and publishing the TANDEM trial demonstrating the lipid lowering efficacy of obicetrapib-ezetimibe FDC thelancet.com/journals/lance…

🚨 Applications open Cleveland Clinic AHFTC Fellowship! 🚨 👨‍⚕️ Lead our 10-bed HF-ICU 🛠️ High procedure volume 🫀 Highest complexity cases 🧪 Clinical trial exposure 🎓 CME + conference funding 🌟 Train with the best! Apply now! ➡️ ERAS by 8/31 #CardioTwitter #MedTwitter @witmcs